13F Portfolios

Lynx1 Capital Management LP: KORRO BIO INC (KRRO): Quarterly 13F Position History

As of Q1 2026, Lynx1 Capital Management LP reported 1,538,296 shares of KORRO BIO INC (KRRO), worth $17.4M and representing 2.8% of its 13F equity book. Quarter-over-quarter share count change: + 860,381 (+126.9%) . The position first appeared in Q2 2024 and has been disclosed across 8 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 8 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 1,538,296 +860,381 +126.9% $17.4M 2.8% $11.3
Q4 2025 677,915 +677,915 $5.4M 1.1% $8.0
Q3 2025 0 0 $0 0.0%
Q2 2025 0 0 $0 0.0%
Q1 2025 0 0 $0 0.0%
Q4 2024 0 0 $0 0.0%
Q3 2024 0 3,800 -100.0% $0 0.0%
Q2 2024 3,800 $128.7K 0.0% $33.9

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Lynx1 Capital Management LP first disclose a KRRO position in 13F-HR filings?

Lynx1 Capital Management LP first reported KORRO BIO INC (KRRO) on its 13F-HR filing for the period ending 2024-06-30 (Q2 2024). The position has appeared on 8 reported quarters within Pactolio's tracked window.

What was Lynx1 Capital Management LP's most recent quarter-over-quarter share-count change in KRRO?

Between Q4 2025 and Q1 2026, Lynx1 Capital Management LP added 860,381 shares of KRRO (+126.9%), bringing the total reported position to 1,538,296 shares at a market value of $17.4M.

Does the implied price-per-share represent Lynx1 Capital Management LP's cost basis in KRRO?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.